跳至主要内容
临床试验/NCT01151748
NCT01151748撤回2 期

Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Stanford University2 个研究点 分布在 1 个国家开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
Response: Globe salvage rate (Eyes saved/Eyes treated). This will be determined by clinical ocular examination.

研究概览

简要总结

Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with advanced intraocular retinoblastoma (International Retinoblastoma Classification group D or E*).
  • Patients with tumor recurrence or vitreous seeding following completion of systemic chemotherapy or previous radiation therapy.

排除标准

  • Congenital brain anomaly identified on MRI.
  • History of systemic coagulopathy.
  • Evidence of extra ocular retinoblastoma on clinical examination or neuroimaging.

结局指标

主要结局

Response: Globe salvage rate (Eyes saved/Eyes treated). This will be determined by clinical ocular examination.

时间窗: Follow-up will be performed for one year from treatment date.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验